Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2

Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2

Abstract Background Genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to emerge in 2020 and have been spreading globally during the coronavirus disease 2019 (COVID-19) pandemic. Despite the presence of different COVID-19 vaccines, the discovery of effective antiv...

Full description

Bibliographic Details
Main Authors: Mya Myat Ngwe Tun, Takaya Sakura, Yasuteru Sakurai, Yohei Kurosaki, Daniel Ken Inaoka, Norifumi Shioda, Jiro Yasuda, Kiyoshi Kita, Kouichi Morita
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Tropical Medicine and Health
Subjects:
SARS-CoV-2 variants
5-ALA
SFC
Anti-viral drug
Online Access:https://doi.org/10.1186/s41182-021-00397-x

Internet

https://doi.org/10.1186/s41182-021-00397-x

Similar Items